Landscape Capital Management, L.L.C. Veracyte, Inc. Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$16.58 - $27.9 $2,818 - $4,743	170 Added 0.17%	100,350 $1.67 Million
Q2 2022 Aug 05, 2022	BUY	$15.45 - $29.52 $1.55 Million - $2.96 Million	100,180 New	100,180 $1.99 Million
Q1 2022 May 11, 2022	SELL	$21.94 - $42.51 $318,963 - $618,010	-14,538 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$36.09 - $53.79 $66,333 - $98,866	1,838 Added 14.47%	14,538 $599,000
Q3 2021 Nov 09, 2021	BUY	$35.62 - $52.97 $452,373 - $672,719	12,700 New	12,700 $590,000
Q4 2020 Feb 09, 2021	SELL	$32.49 - $61.88 $1.21 Million - $2.3 Million	-37,154 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$26.73 - $35.67 $993,126 - $1.33 Million	37,154 New	37,154 $1.21 Million

316

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.